Matthew Kraman
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 7
- Peptidase Inhibition and Analysis 4
- CAR-T cell therapy research 3
-
- Congenital heart defects research 3
- Ubiquitin and proteasome pathways 2
- Co-authors
- Douglas T. Fearon (8 shared papers)David A. Tuveson (3 shared papers)James O. Jones (3 shared papers)Edward W. Roberts (3 shared papers)Łukasz Magiera (2 shared papers)James N. Arnold (2 shared papers)Andrew Deonarine (2 shared papers)Qi Zhao (2 shared papers)
- Journals
- Cancer Immunology Research (3 papers)Developmental Dynamics (2 papers)Cancer Research (2 papers)Proceedings of the National Academy of Sciences (2 papers)Science (2 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Matthew Kraman
19 papers receiving 3.6k citations
Matthew Kraman's Hit Papers
Peers
Comparison fields: 5 of 99
- Oncology 2.4k
- Immunology 1.5k
- Cancer Research 531
- Molecular Biology 1.1k
- Biotechnology 136
Countries citing papers authored by Matthew Kraman
This map shows the geographic impact of Matthew Kraman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Kraman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Kraman more than expected).
Fields of papers citing papers by Matthew Kraman
This network shows the impact of papers produced by Matthew Kraman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Kraman. The network helps show where Matthew Kraman may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew Kraman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer Hit paper breakdown → | 2013 | 1562 |
| 2 | Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α Hit paper breakdown → | 2010 | 953 |
| 3 | 2013 | 314 | |
| 4 | 1996 | 165 | |
| 5 | 2013 | 143 | |
| 6 | 2009 | 130 | |
| 7 | 2020 | 86 | |
| 8 | 2003 | 65 | |
| 9 | 2008 | 64 | |
| 10 | 2006 | 57 | |
| 11 | 2009 | 41 | |
| 12 | 2014 | 30 | |
| 13 | 2018 | 25 | |
| 14 | 2005 | 25 | |
| 15 | 2018 | 13 | |
| 16 | 2010 | 9 | |
| 17 | 2009 | 4 | |
| 18 | 2017 | 3 | |
| 19 | 2019 | 2 | |
| 20 | 2016 | 1 |
About Matthew Kraman
Matthew Kraman is a scholar working on Oncology, Molecular Biology, Immunology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 21 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Immunotherapy and Immune Responses (5 papers), T-cell and B-cell Immunology (4 papers), Immune Cell Function and Interaction (4 papers), Peptidase Inhibition and Analysis (4 papers), Congenital heart defects research (3 papers), CAR-T cell therapy research (3 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Oncology (2.4k citations), Immunology (1.5k citations), Cancer Research (531 citations), Molecular Biology (1.1k citations) and Biotechnology (136 citations). Matthew Kraman has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Douglas T. Fearon, David A. Tuveson, James O. Jones, Edward W. Roberts, Łukasz Magiera, James N. Arnold, Andrew Deonarine, Qi Zhao, Christine Feig and Sarah A. Teichmann. Their work appears in journals such as Cancer Immunology Research, Developmental Dynamics, Cancer Research, Proceedings of the National Academy of Sciences and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.